< Back to previous page
Researcher
Ellen De Langhe
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Skeletal Biology and Engineering Research Center (Division)
Member
From1 Oct 2015 → Today
Projects
1 - 10 of 12
- Unraveling the early events of particle-induced autoimmunity using diverse mouse strains (tentative)From1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A Reproductive Life Plan for women with Systemic Lupus Erythematosus: development and evaluation of user experiencesFrom1 Nov 2021 → 31 Oct 2022Funding: Other federal public and semi-governmental institutions
- Targeted mass spectrometry-based quantification of autoantibodies in systemic rheumatic diseasesFrom1 Oct 2021 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
- Systemic sclerosis and occupational silica or solvent exposure: investigating epidemiology, gene-environment interactions and objective markers of exposure to improve occupational epidemiology, risk assessment and preventionFrom1 Nov 2020 → 31 Oct 2021Funding: Other federal public and semi-governmental institutions
- Systemic sclerosis and occupational silica or solvent exposure: investigating epidemiology, gene-environment interactions and objective markers of exposure to improve occupational epidemiology, risk assessment and prevention.From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Mass spectrometry-based autoantibody tests for specific diagnosis of autoimmune diseasesFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Anti-MDA5 autoantibodies in the pathogenesis of myositis.From1 Dec 2019 → 30 Nov 2020Funding: Other federal public and semi-governmental institutions
- Anti-MDA5 autoantibodies in idiopathic inflammatory myopathies: studies on MDA5 reactivityFrom15 Nov 2019 → 13 Nov 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Development and validation of an assay to quantify anti-dsDNA antibody levels and avidity for more accurate diagnosis and monitoring of SLEFrom1 Oct 2019 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
- Identification and validation of novel autoantibodies in idiopathic in flammatory myopathy.From1 Dec 2018 → 30 Nov 2019Funding: Other federal public and semi-governmental institutions
Publications
1 - 10 of 136
- Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study.(2024)
Authors: Lien Moreel, Geert Molenberghs, Koen Van Laere, Ellen De Langhe, Steven Vanderschueren, Daniel Engelbert Blockmans
Pages: keae208 - Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.(2024)
Authors: Ellen De Langhe
Pages: keae150 - Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort(2024)
Authors: Ellen De Langhe
- Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken(2024)
Authors: Daniel Engelbert Blockmans, Petra De Haes, Ellen De Langhe, Marion Delcroix, Rene Westhovens, Wim Wuyts
Pages: 26 - 33 - Rapidly progressive erosions and ulcerations in a patient with cancer-associated anti-TIF-1γ/α and anti-U1 RNP-positive dermatomyositis: A case report(2023)
Authors: Francesca Bosisio, Ellen De Langhe, Petra De Haes
Pages: E1403 - E1404 - Intrafamilial Correlation and Variability in the Clinical Evolution of Pulmonary Fibrosis(2023)
Authors: Tinne Goos, Marie Vermant, Stefan Gogaert, Laurens De Sadeleer, Ellen De Langhe, Birgit Weynand, Marianne Carlon, Sascha Vermeer, Wim Wuyts
Pages: 1476 - 1480 - Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial(2023)
Authors: Ellen De Langhe
Pages: E660 - E669 - Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes(2023)
Authors: Ellen De Langhe
Pages: 210 - 220 - Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis(2023)
Authors: Rita Derua, Wim Wuyts, Daniel Engelbert Blockmans, Petra De Haes, Ellen De Langhe, Xavier Bossuyt
- Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains(2023)
Authors: Eveline Van Gompel, Ellen De Langhe